Earnings Feed
Start Free
Home/Filings/4/0001144204-18-040243
4//SEC Filing

Sohail Faysal A. 4

Accession 0001144204-18-040243

CIK 0001566044other
View on SEC.govCompany Profile

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 6:54 PM ET

Size

16.7 KB

Accession

0001144204-18-040243

Insider Transaction Report

Form 4
Period: 2018-03-02
Menlo Therapeutics Inc.MNLO
Presidio Partners 2007 GP, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410
Collier David J
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410
Watson James F
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410
Sohail Faysal A.
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410
CMEA VENTURES VII (PARALLEL) LP
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068
CMEA Ventures VII LP
10% Owner
Transactions
  • Other

    Common Stock

    2018-03-02+152,062→ 152,062 total(indirect: By David J. Collier)
Holdings

  • Common Stock

    (indirect: By Presidio Partners 2007, L.P.)
    2,395,068

  • Common Stock

    (indirect: By Presidio Partners 2007 (Parallel), L.P.)
    61,410
Footnotes (4)
  • [F1]Pro rata distribution from Velocity Pharmaceutical Development, LLC, of which the reporting person is a non-managing member.
  • [F2]Securities directly held by David J. Collier, M.D., a general partner of Presidio GP (as defined below), which is the sole general partner of Presidio Partners (as defined below).
  • [F3]Securities directly held by Presidio Partners 2007, L.P. ("Presidio Partners"). Presidio Partners 2007 GP, L.P. ("Presidio GP") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein.
  • [F4]Securities directly held by Presidio Partners 2007 (Parallel), L.P. ("Presidio Parallel"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein.

Documents

1 file

Issuer

Menlo Therapeutics Inc.

CIK 0001566044

→
Entity typeother

Related Parties

1
  • filerCIK 0001425394

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 6:54 PM ET
Size
16.7 KB
View on SEC.gov